Actively Recruiting
Personalized Brain Stimulation Therapy Targeting Anhedonia in Older Adults with Depression Evaluating Treatment Effects and Brain Mechanisms
Led by Jie Li · Updated on 2026-06-10
80
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying personalized transcranial alternating current stimulation tACS as a treatment for anhedonia in older adults with late-life depression LLD. This research addresses challenges with current drug treatments by exploring a non-invasive brain stimulation method that may improve depressive symptoms. The study aims to optimize tACS treatment using randomized, double-blind, controlled trials and deep learning to create precise treatment protocols. Participants will receive either real or sham tACS targeting the prefrontal cortex with a 1 mA, 40 Hz sinusoidal waveform. The study evaluates short-term 2 weeks and long-term 3 months effects on depressive symptoms and anhedonia using scales like the Hamilton Depression Scale HAMD, Dimensional Anhedonia Rating Scale DARS, and Snaith-Hamilton Pleasure Scale SHAPS. Multimodal monitoring, including 64-channel EEG and measurements of inflammatory factors and neurotransmitters, will help understand how tACS affects brain activity and chemical regulation. During the study, participants will undergo brain stimulation sessions and multiple assessments to measure mood, anhedonia, and brain function. Researchers will track changes in neural oscillations, synaptic plasticity markers, and neurotransmitter levels to understand the treatments mechanisms. Safety and tolerability will also be monitored. The total participation includes baseline evaluations, treatment sessions, and follow-up assessments over 12 weeks to measure outcomes and long-term effects.
CONDITIONS
Brief Title
Investigating the Efficacy and Mechanisms of Individualized tACS Targeting Anhedonia in Late-Life Depression
Research Team
D
Daliang Sun Da liang Sun, Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here